BioSpace News Archive

Vaccination is one of the most cost-effective and safest ways to prevent diseases. Pneumococcus is one of the major causes of blood infection, pneumonia, sinusitis, meningitis, and otitis media.

Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced that it will release fiscal second quarter 2021 financial results on Wednesday, October 14, 2020, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. E.D.T. on the same day. Co

Oral presentation of interim results from TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) open-label safety extension study to be presented at the ECFS Digital Conference

IDEAYA Biosciences, Inc. announced that it has expanded its clinical trial collaboration and supply agreement with Pfizer Inc. for an IDEAYA sponsored clinical combination study of IDE196, a Protein Kinase C inhibitor, and crizotinib, a cMET inhibitor to which Pfizer has exclusive worldwide rights.

Generation Bio Co., an innovative genetic medicines company creating a new class of non-viral gene therapy, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the Jefferies 2020 Virtual Gene Therapy/Editing Summit on Thursday, Oct. 1 at 11:00 a.m. ET.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced positive clinical findings published in Cancer Chemotherapy and Pharmacology regarding MN-166 as a treatment for prevention of chemotherapy-induced peripheral neuropathy.

ViewRay, Inc. announced that Chungnam National University Sejong Hospital in Sejong, South Korea has begun patient treatments with the MRIdian® MRI-Guided Therapy System, a cutting-edge radiation therapy device that combines the latest innovations in precision radiation delivery and ground-breaking MRI-guidance.

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that its Logix Smart™ ABC Test is anticipated to be ready for launch to US CLIA laboratory customers the first week of October 2020.

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that it will participate in the 75th Annual Meeting of the American Society for Surgery of the Hand being held virtually from October 1-3, 2020.

KYAN Therapeutics, Inc., a frontier biotech company with a novel drug-dose combination optimizing platform, Optim.AI, has entered into an exclusive license agreement with Georgetown University for novel selective Class II HDAC inhibitors.